Meningococcal Group A Polysaccharide-Tetanus Toxoid Conjugate + Meningococcal Group C Polysaccharide-Tetanus Toxoid Conjugate + Meningococcal Group W Polysaccharide-Tetanus Toxoid Conjugate + Meningococcal Group Y Polysaccharide-Tetanus Toxoid Conjugate + Meningococcal Polysaccharide Group A + Meningococcal Polysaccharide Group C + Meningococcal Polysaccharide Group W135 + Meningococcal Polysaccharide Group Y + Tetanus Toxoid + Vacuna Anti Meningococo A/C/W135/Y

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
MENQUADFIAU CA ES EU
  • injection ×3 Vacuna Anti Meningococo A/C/W135/Y
  • liquid Meningococcal Group A Polysaccharide-Tetanus Toxoid Conjugate 0.01 mg + Meningococcal Group C Polysaccharide-Tetanus Toxoid Conjugate 0.01 mg + Meningococcal Group W Polysaccharide-Tetanus Toxoid Conjugate 0.01 mg + Meningococcal Group Y Polysaccharide-Tetanus Toxoid Conjugate 0.01 mg + Tetanus Toxoid 0.055 mg
  • unknown Meningococcal Polysaccharide Group A + Meningococcal Polysaccharide Group C + Meningococcal Polysaccharide Group W135 + Meningococcal Polysaccharide Group Y
SANOFI VACCINES CANADA LTD.

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.